<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" dms-id="H8C6ABF423D0243A4BAA284518D4FB54E" public-private="public" key="H" bill-type="olc">
<metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>118 HR 5818 IH: Medicare IVIG Access Enhancement Act of 2023</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2023-09-28</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code>
<congress display="yes">118th CONGRESS</congress><session display="yes">1st Session</session>
<legis-num display="yes">H. R. 5818</legis-num>
<current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber>
<action display="yes">
<action-date date="20230928">September 28, 2023</action-date>
<action-desc><sponsor name-id="S001172">Mr. Smith of Nebraska</sponsor> (for himself and <cosponsor name-id="G000559">Mr. Garamendi</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name>, and in addition to the Committee on <committee-name committee-id="HWM00">Ways and Means</committee-name>, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned</action-desc>
</action>
<legis-type>A BILL</legis-type>
<official-title display="yes">To amend title XVIII of the Social Security Act to expand coverage of the in-home administration of intravenous immune globulin under the Medicare program.</official-title>
</form>
<legis-body id="H88B831F2EDE740ECB0FA6B86937C3C41" style="OLC">
<section id="H3F864D9EB01440B6B639C41FD542A4B1" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Medicare IVIG Access Enhancement Act of 2023</short-title></quote>.</text></section> <section id="H926A6ACF4B6F4E4C92C513951EEE0EC1"><enum>2.</enum><header>Expanding coverage of the in-home administration of intravenous immune globulin under the Medicare program</header> <subsection id="H28A14890EC514687BFAF86A42CD036EB"><enum>(a)</enum><header>In general</header><text display-inline="yes-display-inline">Section 1861 of the Social Security Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1395x">42 U.S.C. 1395x</external-xref>) is amendedâ€”</text>
<paragraph id="HC1E288C38EF043309CF611971F55A8C7"><enum>(1)</enum><text>in subsection (s)(2)(Z), by inserting <quote>(and, beginning January 1, 2026, for the treatment of chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy)</quote> after <quote>primary immune deficiency diseases</quote>; and</text></paragraph> <paragraph id="H3014F95AF74E4B07821ECE705DFC280B"><enum>(2)</enum><text>in subsection (zz), by inserting <quote>(or, beginning January 1, 2026, with diagnosed chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy)</quote> after <quote>primary immune deficiency disease</quote>. </text></paragraph></subsection>
<subsection id="HABF677547B1E44CEAE84DA6D1E107C18"><enum>(b)</enum><header>Authority for variance in payments</header><text display-inline="yes-display-inline">Section 1842(o)(8) of the Social Security Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1395u">42 U.S.C. 1395u(o)(8)</external-xref>) is amended by inserting <quote>and may vary depending on whether such administration is related to treatment of a primary immune deficiency disease or the treatment of chronic inflammatory demyelinating polyneuropathy or multifocal motor neuropathy (as determined appropriate by the Secretary through notice and comment rulemaking)</quote> after <quote>of 2012</quote>. </text></subsection></section> </legis-body> </bill> 

